These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22653800)

  • 1. Treatment of immune thrombocytopenia with intravenous immunoglobulin and insights for other diseases. A historical review.
    Imbach P
    Swiss Med Wkly; 2012; 142():w13593. PubMed ID: 22653800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).
    Imbach P; Morell A
    Int Rev Immunol; 1989; 5(2):181-8. PubMed ID: 8691051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
    Blanchette VS; Kirby MA; Turner C
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
    Blanchette V; Carcao M
    Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action.
    Lazarus AH; Freedman J; Semple JW
    Transfus Sci; 1998 Sep; 19(3):289-94. PubMed ID: 10351141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of intravenous immunoglobulin in the treatment of immune thrombocytopenia.
    Crow AR; Song S; Siragam V; Lazarus AH
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):710-3. PubMed ID: 16933274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of IVIG action in immune thrombocytopenic purpura.
    Hansen RJ; Balthasar JP
    Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic autoimmune thrombocytopenic purpura (ITP) in adults.
    Garvey B
    Transfus Sci; 1998 Sep; 19(3):269-77. PubMed ID: 10351139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
    Tremblay T; Paré I; Bazin R
    Transfusion; 2013 Feb; 53(2):261-9. PubMed ID: 22670706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive-transfer effects of intravenous immunoglobulin in autoimmunity.
    Lazarus AH
    J Clin Immunol; 2010 May; 30 Suppl 1():S20-3. PubMed ID: 20401687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
    Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
    Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.
    Ibáñez C; Montoro-Ronsano JB
    Curr Pharm Biotechnol; 2003 Aug; 4(4):239-47. PubMed ID: 14529426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic principles of intravenous immunoglobulin (IVIg) treatment.
    Stangel M; Pul R
    J Neurol; 2006 Sep; 253 Suppl 5():V18-24. PubMed ID: 16998749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profiles in mouse models of experimental immune thrombocytopenia reveal a lack of inflammation and differences in response to intravenous immunoglobulin depending on the mouse strain.
    Leontyev D; Neschadim A; Branch DR
    Transfusion; 2014 Nov; 54(11):2871-9. PubMed ID: 24826802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy of autoimmune and systemic inflammatory diseases.
    Ronda N; Hurez V; Kazatchkine MD
    Vox Sang; 1993; 64(2):65-72. PubMed ID: 8456559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic intravenous immunoglobulins.
    Lemieux R; Bazin R; Néron S
    Mol Immunol; 2005 May; 42(7):839-48. PubMed ID: 15829272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal IgG can ameliorate immune thrombocytopenia in a murine model of ITP: an alternative to IVIG.
    Song S; Crow AR; Freedman J; Lazarus AH
    Blood; 2003 May; 101(9):3708-13. PubMed ID: 12506021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia.
    Hansen RJ; Balthasar JP
    J Pharm Sci; 2003 Jun; 92(6):1206-15. PubMed ID: 12761810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.